Discover 661 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 661
Hybrid Group Singing
for
Coronary Artery Disease, Elderly
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 55 - 70+
Code: NCT07355192
Recruiting
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Milwaukee WI, Chicago IL, Indianapolis IN, Gahanna OH,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase2, Phase3, Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Location: Milwaukee WI, Madison WI, Iowa City IA, Columbus OH,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 19+
Code: NCT06974786
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
for
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor,
Location: Milwaukee WI, Rochester MN, Iowa City IA, Detroit MI,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT07087054
Phase3, Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Location: Milwaukee WI, Madison WI, North Chicago IL, Chicago IL,
Sponsor: Duke University
Sex: All
Age: 70+
Code: NCT04262206
Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Milwaukee WI, Madison WI, Chicago IL, Peoria IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Milwaukee WI, Madison WI, Chicago IL, Detroit MI,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT06787612
Phase2, Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: Milwaukee WI, Greenfield WI, Chicago IL, Owosso MI,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase3, Recruiting
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
for
Lung Cancer (Diagnosis)
Location: Milwaukee WI, North Chicago IL, Dayton OH, DuBois PA,
Sponsor: bioAffinity Technologies Inc.
Sex: All
Age: 50 - 70+
Code: NCT07168993
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Location: Milwaukee WI, Chapel Hill NC, New York NY, New Haven CT,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sex: All
Age: 18+
Code: NCT06656494
Phase1, Recruiting
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
for
High Risk Pregnancy, Congenital Heart Disease, Fetal Hydrops,
Location: Milwaukee WI, Madison WI
Sponsor: Medical College of Wisconsin
Sex: Female
Age: 18+
Code: NCT03775954
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Location: Milwaukee WI, Evanston IL, Rock Island IL, Ann Arbor MI,
Sponsor: Hamilton Health Sciences Corporation
Sex: All
Age: 18+
Code: NCT05963698
Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Milwaukee WI, Madison WI, Chicago IL, Columbus OH,